CareDx Inc

17.88
-0.47 (-2.56%)
At close: Mar 28, 2025, 2:54 PM

CareDx Inc Statistics

Share Statistics

CareDx Inc has 55.43M shares outstanding. The number of shares has increased by 3.58% in one year.

Shares Outstanding 55.43M
Shares Change (YoY) 3.58%
Shares Change (QoQ) 1.69%
Owned by Institutions (%) 99.99%
Shares Floating 51.94M
Failed to Deliver (FTD) Shares 12.8K
FTD / Avg. Volume 1.5%

Short Selling Information

The latest short interest is 4.39M, so 8.18% of the outstanding shares have been sold short.

Short Interest 4.39M
Short % of Shares Out 8.18%
Short % of Float 8.74%
Short Ratio (days to cover) 5.27

Valuation Ratios

The PE ratio is 21.5 and the forward PE ratio is 40.07. CareDx Inc's PEG ratio is -0.17.

PE Ratio 21.5
Forward PE 40.07
PS Ratio 3.39
Forward PS 1.8
PB Ratio 2.99
P/FCF Ratio 29.7
PEG Ratio -0.17
Financial Ratio History

Enterprise Valuation

CareDx Inc has an Enterprise Value (EV) of 597.2M.

EV / Earnings 11.36
EV / Sales 1.79
EV / EBITDA -17.57
EV / EBIT 14.65
EV / FCF 15.7

Financial Position

The company has a current ratio of 3.94, with a Debt / Equity ratio of 0.06.

Current Ratio 3.94
Quick Ratio 3.72
Debt / Equity 0.06
Total Debt / Capitalization 5.56
Cash Flow / Debt 1.71
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is 0.14% and return on capital (ROIC) is 10.11%.

Return on Equity (ROE) 0.14%
Return on Assets (ROA) 0.11%
Return on Capital (ROIC) 10.11%
Revenue Per Employee $518,299.69
Profits Per Employee $81,597.83
Employee Count 644
Asset Turnover 0.68
Inventory Turnover n/a

Taxes

Income Tax 310K
Effective Tax Rate 0.01

Stock Price Statistics

The stock price has increased by 73.65% in the last 52 weeks. The beta is 1.95, so CareDx Inc's price volatility has been higher than the market average.

Beta 1.95
52-Week Price Change 73.65%
50-Day Moving Average 21.44
200-Day Moving Average 23.04
Relative Strength Index (RSI) 40.12
Average Volume (20 Days) 854.19K

Income Statement

In the last 12 months, CareDx Inc had revenue of 333.79M and earned 52.55M in profits. Earnings per share was 1.

Revenue 333.79M
Gross Profit 333.79M
Operating Income 40.77M
Net Income 52.55M
EBITDA -33.99M
EBIT 40.77M
Earnings Per Share (EPS) 1
Full Income Statement

Balance Sheet

The company has 114.69M in cash and 22.26M in debt, giving a net cash position of 92.43M.

Cash & Cash Equivalents 114.69M
Total Debt 22.26M
Net Cash 92.43M
Retained Earnings -626.24M
Total Assets 491.05M
Working Capital 262.46M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 38.05M and capital expenditures 0, giving a free cash flow of 38.05M.

Operating Cash Flow 38.05M
Capital Expenditures 0
Free Cash Flow 38.05M
FCF Per Share 0.72
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of 12.21% and 15.74%.

Gross Margin 100%
Operating Margin 12.21%
Pretax Margin 15.84%
Profit Margin 15.74%
EBITDA Margin -10.18%
EBIT Margin 12.21%
FCF Margin 11.4%

Dividends & Yields

CDNA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield 5.44%
FCF Yield 3.73%
Dividend Details

Analyst Forecast

The average price target for CDNA is $33.5, which is 82.2% higher than the current price. The consensus rating is "Buy".

Price Target $33.5
Price Target Difference 82.2%
Analyst Consensus Buy
Analyst Count 7
Stock Forecasts

Scores

Altman Z-Score 5.48
Piotroski F-Score 5